Product Description: XRD-0394 is a potent and specific dual inhibitor of ATM and DNA-PKcs with oral activity. XRD-0394 significantly enhances tumor cell killing in vitro and in vivo under therapeutic ionizing radiation conditions. In addition, XRD-0394 can potentiate the effects of PARP and topoisomerase I inhibitors in vitro[1].
Formula: C26H30FN5O4S
References: [1]Gilmer T M, et al. A novel dual ATM/DNA-PK inhibitor, XRD-0394, potently radiosensitizes and potentiates PARP and topoisomerase I inhibitors[J]. Molecular Cancer Therapeutics, 2024.
CAS Number: 2595308-10-2
Molecular Weight: 527.61
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: ATM/ATR;DNA-PK